Valley National Advisers Inc Abbott Laboratories Transaction History

Valley National Advisers Inc

$554 Million
Q3 2024

A detailed history of Valley National Advisers Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Valley National Advisers Inc holds 901 shares of ABT stock, worth $103,398. This represents 0.02% of its overall portfolio holdings.

Number of Shares

901

Previous 1,364 33.94%

Holding current value

$103,398

Previous $141,000 27.66%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $46,332 - $54,694	-463 Reduced 33.94%	901 $102,000
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $6,043 - $6,746	-60 Reduced 4.21%	1,364 $141,000
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $7,447 - $8,225	-68 Reduced 4.56%	1,424 $161,000
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $144,213 - $176,529	-1,599 Reduced 51.73%	1,492 $164,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $19,870 - $23,840	208 Added 7.21%	3,091 $300,000
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $3,527 - $3,930	35 Added 1.23%	2,883 $316,000
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $26,055 - $30,668	269 Added 10.43%	2,848 $315,000
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $2,186 - $2,564	23 Added 0.9%	2,579 $291,000
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $144,326 - $174,445	1,414 Added 123.82%	2,556 $280,000
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $53,143 - $65,071	460 Added 67.45%	1,142 $161,000
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $13,329 - $15,690	-126 Reduced 15.59%	682 $79,000
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $10,013 - $11,797	-92 Reduced 10.22%	808 $97,000
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $510,405 - $556,195	-4,861 Reduced 84.38%	900 $99,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $28,225 - $34,277	-308 Reduced 5.07%	5,761 $626,000
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $14,931 - $19,110	-195 Reduced 3.11%	6,069 $555,000
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $2,575 - $3,766	-41 Reduced 0.65%	6,264 $494,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $12,247 - $13,634	-156 Reduced 2.41%	6,305 $548,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $4,092 - $4,437	-50 Reduced 0.77%	6,461 $541,000
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $25,653 - $29,920	-352 Reduced 5.13%	6,511 $548,000
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $280,574 - $339,214	-4,237 Reduced 38.17%	6,863 $549,000
Q4 2018 Feb 25, 2019	BUY	$65.56 - $74.27 $4,261 - $4,827	65 Added 0.59%	11,100 $803,000
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $24,688 - $29,784	-406 Reduced 3.55%	11,035 $810,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $1,727 - $1,906	-30 Reduced 0.26%	11,441 $698,000
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $10,353 - $11,706	-184 Reduced 1.58%	11,471 $687,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $77,245 - $82,699	-1,439 Reduced 10.99%	11,655 $665,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $629,297 - $702,362	13,094	13,094 $699,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.

Account

Valley National Advisers Inc Abbott Laboratories Transaction History